Format
Items per page
Sort by

Send to:

Choose Destination

Selected items

Items: 20

1.
2.

Treatment of warfarin-associated coagulopathy with vitamin K.

Patriquin C, Crowther M.

Expert Rev Hematol. 2011 Dec;4(6):657-65; quiz 666-7. doi: 10.1586/ehm.11.59. Review.

PMID:
22077529
3.
4.

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.

Ezekowitz MD, Wallentin L, Connolly SJ, Parekh A, Chernick MR, Pogue J, Aikens TH, Yang S, Reilly PA, Lip GY, Yusuf S; RE-LY Steering Committee and Investigators.

Circulation. 2010 Nov 30;122(22):2246-53. doi: 10.1161/CIRCULATIONAHA.110.973735.

5.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
6.

Warfarin and vitamin K intake in the era of pharmacogenetics.

Lurie Y, Loebstein R, Kurnik D, Almog S, Halkin H.

Br J Clin Pharmacol. 2010 Aug;70(2):164-70. doi: 10.1111/j.1365-2125.2010.03672.x. Review.

7.

Vitamin K: a practical guide to the dietary management of patients on warfarin.

Booth SL, Centurelli MA.

Nutr Rev. 1999 Sep;57(9 Pt 1):288-96. Review.

PMID:
10568341
8.

Clinical experience with oral versus intravenous vitamin K for warfarin reversal.

Meehan R, Tavares M, Sweeney J.

Transfusion. 2013 Mar;53(3):491-8; quiz 490. doi: 10.1111/j.1537-2995.2012.03755.x. Epub 2012 Jun 28.

PMID:
22738309
9.
10.

The vitamin K-antagonism of salicylate and warfarin.

Roncaglioni MC, Ulrich MM, Muller AD, Soute BA, de Boer-van den Berg MA, Vermeer C.

Thromb Res. 1986 Jun 15;42(6):727-36.

PMID:
3726797
11.

Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.

Dickerson RN.

Nutrition. 2008 Oct;24(10):1048-52. doi: 10.1016/j.nut.2008.05.015. Epub 2008 Jul 7. Review. No abstract available.

PMID:
18602249
12.

Vitamin K-dependent proteins, warfarin, and vascular calcification.

Danziger J.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1504-10. doi: 10.2215/CJN.00770208. Epub 2008 May 21. Review.

13.
14.

The effect of vitamin E on warfarin-induced vitamin K deficiency.

Corrigan JJ Jr.

Ann N Y Acad Sci. 1982;393:361-8.

PMID:
6959563
15.

Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.

Tsu LV, Dienes JE, Dager WE.

Ann Pharmacother. 2012 Dec;46(12):1617-26. doi: 10.1345/aph.1R497. Epub 2012 Dec 18.

PMID:
23249867
16.

Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.

Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C.

Blood. 2007 Apr 1;109(7):2823-31.

17.

Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.

McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, Holden RM.

Kidney Int. 2013 May;83(5):835-44. doi: 10.1038/ki.2012.477. Epub 2013 Jan 23.

PMID:
23344475
18.

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE.

Br J Haematol. 2001 Oct;115(1):145-9.

PMID:
11722425
20.

Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin.

Kim KH, Choi WS, Lee JH, Lee H, Yang DH, Chae SC.

Thromb Haemost. 2010 Oct;104(4):755-9. doi: 10.1160/TH10-04-0257. Epub 2010 Jul 20.

PMID:
20664899
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk